Agilon Health

Agilon Health, Inc. is a healthcare company, enables primary care physicians (PCPs) to be agents in the communities they serve. It provides healthcare for seniors across communities throughout the United States and has created an agilon Platform, which is a Total Care Model for community-based physicians. The firm serves a Total Care Model which focuses exclusively on Medicare and manages the comprehensive healthcare needs of its members through subscription-like member per month arrangements with health plans or directly with the Centers for Medicare and Medicaid services. The company was founded in 2016 and is headquartered in Austin, TX.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Agilon Health reports strong 2022 performance and optimistic growth outlook

Agilon Health had a successful 2022, with strong financial performance and a focus on transforming healthcare through empowering primary care doctors. The company is optimistic about future growth, managing challenges in margins and financial management while leveraging opportunities in partnerships and operational efficiency.

Agilon Health triples Q1 earnings, eyes growth through partnerships

Agilon Health (AGL) delivered robust Q1 2023 results, maintaining outlook and confidence in clinical programs for high-cost patients and new partnerships.
Effective management of costs and revenues, alongside strategic acquisitions and partnerships, underpin the company's growth trajectory.
Challenges include margin impacts from external factors and managing costs associated with market expansion, balanced by opportunities in network growth and market transition.
The company's performance, strengths, challenges, and opportunities collectively shape its strategic direction towards sustained growth and operational excellence.

Agilon Health excels in Q2 2023, eyes growth opportunities

Agilon Health's strong financial performance in Q2 2023 underscores its operational excellence and growth potential. While challenges like revenue projections and medical margin variations exist, the company's strategic focus on risk adjustment and payer partnerships presents significant opportunities for future success.

Agilon Health reports strong Q3 performance, eyes growth opportunities

Agilon Health's Q3 2023 performance reflects robust growth in partner markets and revenue, supported by a unique model driving clinical and financial success.
While facing challenges in cash flow and benefit pullbacks, the company is well-positioned to leverage opportunities for growth and operational enhancement in '24.
Strategic decisions like selling the Hawaii business and focusing on core markets demonstrate a commitment to sustainable growth and operational efficiency.

Agilon Health addresses challenges, focuses on growth opportunities in 2024

Agilon Health faces challenges with medical margins but is making progress on their 2024 performance action plan to drive improvement.
The company is focusing on data visibility, quality partnerships, and efficiency gains to navigate the dynamic utilization environment and achieve growth.
Despite higher cash burn in 2024, Agilon anticipates positive cash flow from 2025 onwards if they meet their guidance and address payer negotiations.
Opportunities lie in a measured growth approach, cohort progression, and tuning payer arrangements to reflect the value provided by Agilon's services.

Agilon Health reports strong Q1 growth, navigates healthcare challenges

Agilon Health's Q1 '24 performance showcased growth in membership, revenue, medical margin, and adjusted EBITDA, despite challenges in cost trends and utilization.
The company's strategic focus on value-based care partnerships, data analytics, and operational efficiency positions them well for future growth and profitability.
While facing challenges in cost management and contract negotiations, Agilon Health is actively pursuing opportunities in sustainable payer contracts, technology enhancements, and benefit expansions.

Agilon Health reports strong Q2 performance and strategic growth outlook

Agilon Health's Q2 2024 earnings call reflects robust performance, operational strengths, strategic challenges, and growth opportunities in the evolving healthcare landscape.
The company's focus on refining payer relationships, enhancing data visibility, and driving operational efficiency positions it well for sustained success and market expansion.
Despite facing financial challenges and navigating payer dynamics, Agilon Health's proactive approach to innovation and leadership changes signals a commitment to long-term growth and value creation.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Agilon Health, Inc. engages in providing healthcare services. It also provides the technology, people, capital, process, and access to a peer network of primary care physicians. The company was founded by Ronald A. Williams and Veeral Desai in 2016 and is headquartered in Austin, TX.

LOS ANGELES, CA / ACCESSWIRE / May 18, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against agilon health, inc. ("agilon" or "the Company") (NYSE:AGL) for violations of 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.

IMPORTANT SHAREHOLDER ALERT: The Schall Law Firm Encourages Investors in agilon health, inc. with Losses of $100,000 to Contact the Firm

BENSALEM, Pa. , May 17, 2024 /PRNewswire/ -- Law Offices of Howard G.

AGL Investors Have Opportunity to Lead agilon health, inc. Securities Fraud Lawsuit

LOS ANGELES, CA / ACCESSWIRE / May 17, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against agilon health, inc. ("agilon" or "the Company") (NYSE:AGL) for violations of 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.

DEADLINE ACTION NOTICE: The Schall Law Firm Encourages Investors in agilon health, inc. with Losses of $100,000 to Contact the Firm

NEW YORK, NY / ACCESSWIRE / May 17, 2024 / If you suffered a loss on your agilon health, inc. (NYSE:AGL) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/agilon-health-lawsuit-submission-form?prid=80398&wire=1 or contact Joseph E.

Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of May 20, 2024 in agilon health Lawsuit - AGL

NEW YORK , May 16, 2024 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against agilon health, inc. ("Agilon" or the "Company") (NYSE: AGL).

SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against agilon health, inc. - AGL

NEW YORK, NY / ACCESSWIRE / May 16, 2024 / If you suffered a loss on your agilon health, inc. (NYSE:AGL) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/agilon-health-lawsuit-submission-form?prid=80141&wire=1 or contact Joseph E.

agilon health, inc. Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky Before May 20, 2024 to Discuss Your Rights - AGL

NEW YORK , May 15, 2024 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in agilon health, inc. ("agilon health" or the "Company") (NYSE: AGL) of a class action securities lawsuit.

May 20, 2024 Deadline: Contact Levi & Korsinsky to Join Class Action Suit Against AGL

NEW YORK, NY / ACCESSWIRE / May 14, 2024 / If you suffered a loss on your agilon health, inc. (NYSE:AGL) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/agilon-health-lawsuit-submission-form?prid=79703&wire=1 or contact Joseph E.

agilon health, inc. Sued for Securities Law Violations - Contact Levi & Korsinsky Before May 20, 2024 to Discuss Your Rights - AGL

NEW YORK , May 14, 2024 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of agilon health, inc. (NYSE: AGL).

The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of May 20, 2024 in agilon health Lawsuit - AGL

NEW YORK, NY / ACCESSWIRE / May 13, 2024 / If you suffered a loss on your agilon health, inc. (NYSE:AGL) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/agilon-health-lawsuit-submission-form?prid=79491&wire=1 or contact Joseph E.

Contact Levi & Korsinsky by May 20, 2024 Deadline to Join Class Action Against agilon health, inc.(AGL)

NEW YORK , May 13, 2024 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in agilon health, inc. ("agilon health" or the "Company") (NYSE: AGL) of a class action securities lawsuit.

Investors who lost money on agilon health, inc.(AGL) should contact Levi & Korsinsky about pending Class Action - AGL

NEW ORLEANS , May 10, 2024 /PRNewswire/ -- Kahn Swick & Foti, LLC ("KSF") and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they have until May 20, 2024 to file lead plaintiff applications in securities class action lawsuits against agilon health, inc.

AGILON HEALTH SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Reminds Investors with Losses in Excess of $100,000 of Lead Plaintiff Deadline in Class Action Lawsuits Against agilon health, inc. - AGL

RADNOR, Pa. , May 9, 2024 /PRNewswire/ -- The law firm of Kessler Topaz Meltzer & Check, LLP informs investors that the firm has filed a securities fraud class action lawsuit against agilon health, inc.

Kessler Topaz Meltzer & Check, LLP Reminds agilon health, inc. Investors of Important Deadline in Securities Fraud Class Action Lawsuit (AGL)

LOS ANGELES, CA / ACCESSWIRE / May 9, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against agilon health, inc. ("agilon" or "the Company") (NYSE:AGL) for violations of 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.

IMPORTANT INVESTOR ALERT: The Schall Law Firm Encourages Investors in agilon health, inc. with Losses of $500,000 to Contact the Firm

NEW YORK, NY / ACCESSWIRE / May 9, 2024 / If you suffered a loss on your agilon health, inc. (NYSE:AGL) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/agilon-health-lawsuit-submission-form?prid=78921&wire=1 or contact Joseph E.

Investors who Lost Money on Agilon Health, inc.(AGL) Should Contact Levi & Korsinsky about pending Class Action - AGL

agilon health, inc. (NYSE:AGL ) Q1 2024 Earnings Conference Call May 7, 2024 4:30 PM ET Company Participants Matthew Gillmor - VP, IR Steve Sell - CEO Tim Bensley - CFO Conference Call Participants Ryan Daniels - William Blair Dean Rosales - Wolfe Research Jailendra Singh - Truist Adam Ron - Bank of America Sean Dodge - RBC Capital Markets Jack Slevin - Jefferies George Hill - Deutsche Bank Sameer Patel - Evercore ISI Operator Hello, everyone, and welcome to the agilon health First Quarter 2024 Earnings Conference.

agilon health, inc. (AGL) Q1 2024 Earnings Call Transcript

Although the revenue and EPS for Agilon (AGL) give a sense of how its business performed in the quarter ended March 2024, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.

Agilon (AGL) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates

AUSTIN, Texas--(BUSINESS WIRE)--agilon health, inc. (NYSE: AGL), the trusted partner empowering physicians to transform health care in our communities, announced results for the first quarter ended March 31, 2024. “Our first quarter results were in-line with our guidance,” said Steve Sell, chief executive officer. “We continue to make tangible progress executing our performance action plan. As payors adjust to the current funding environment for Medicare Advantage, we remain well positioned as.

agilon health Reports First Quarter 2024 Results

AUSTIN, Texas--(BUSINESS WIRE)--agilon health (NYSE: AGL), the trusted partner empowering physicians to transform health care in our communities, today announced that it has formed long-term partnerships with five new physician practices across the U.S. to enable their transition to a full-risk, value-based care model. Recognized leaders in their respective communities, the new partners include Graves Gilbert Clinic in Kentucky, Mankato Clinic in Minnesota, Springfield Clinic in Illinois, and T.

agilon health Announces New Physician Partnerships for 2025

LOS ANGELES , May 7, 2024 /PRNewswire/ --  The Schall Law Firm , a national shareholder rights litigation firm, reminds investors of a class action lawsuit against agilon health, inc. ("agilon" or "the Company") (NYSE: AGL) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.

SHAREHOLDER ACTION ALERT: The Schall Law Firm Encourages Investors in agilon health, inc. with Losses of $100,000 to Contact the Firm

NEW YORK, NY / ACCESSWIRE / May 7, 2024 / If you suffered a loss on your agilon health, inc. (NYSE:AGL) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/agilon-health-lawsuit-submission-form?prid=78428&wire=1 or contact Joseph E.

Lost Money on agilon health, inc.(AGL)? Join Class Action Suit Seeking Recovery - Contact Levi & Korsinsky

NEW YORK , May 7, 2024 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of agilon health, inc. (NYSE: AGL).

agilon health, inc. Class Action: The Gross Law Firm Reminds agilon health Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of May 20, 2024 - AGL

NEW YORK, NY / ACCESSWIRE / May 6, 2024 / If you suffered a loss on your agilon health, inc. (NYSE:AGL) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/agilon-health-lawsuit-submission-form?prid=78249&wire=1 or contact Joseph E.

Class Action Filed Against agilon health, inc. (AGL) Seeking Recovery for Investors - Contact Levi & Korsinsky

NEW ORLEANS , May 3, 2024 /PRNewswire/ -- ClaimsFiler, a FREE shareholder information service, reminds investors that they have until May 20, 2024 to file lead plaintiff applications in a securities class action lawsuit against agilon health, inc. ("agilon" or the "Company") (NYSE: AGL), if they: i) purchased or otherwise acquired the Company's shares between April 15, 2021 and February 27, 2024, inclusive (the "Class Period"), and/or ii) purchased or otherwise acquired the Company's shares pursuant or traceable to the Company's April 2021 initial public offering ("IPO"), and/or iii) purchased or otherwise acquired the Company's shares pursuant or traceable to the Company's May 2023 secondary public offering ("SPO").

AGILON HEALTH SHAREHOLDER ALERT: CLAIMSFILER REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuits Against agilon health, inc. - AGL

NEW YORK , May 3, 2024 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of agilon health, inc. (NYSE: AGL).

News for Agilon Health Stock (AGL)